2004
Marked hyperkalemia was observed during and immediately after an infusion of arginine monohydrochloride in two patients with severe hepatic disease and moderate renal insufficiency.
 two patients with severe hepatic disease and moderate renal insufficiency: Subject; two: Subject.Population; moderate renal insufficiency: Subject.Disorder; Marked hyperkalemia: Effect; during and immediately after an infusion of arginine monohydrochloride: Treatment; arginine monohydrochloride: Treatment.Drug; infusion: Treatment.Route; immediately: Treatment.Time_elapsed; hepatic disease: Treatment.Disorder
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 two patients with severe hepatic disease and moderate renal insufficiency: Subject; two: Subject.Population; moderate renal insufficiency: Subject.Disorder; Marked hyperkalemia: Effect; during and immediately after an infusion of arginine monohydrochloride: Treatment; arginine monohydrochloride: Treatment.Drug; infusion: Treatment.Route; immediately: Treatment.Time_elapsed; hepatic disease: Treatment.Disorder